REMEDY PLAN THERAPEUTICS

remedy-plan-therapeutics-logo

Remedy Plan Therapeutics is a pre-clinical-stage company developing small molecule therapeutics to halt tumor growth and disrupt the cancer stem cells that cause metastasis. Our approach is to develop effective, non-toxic treatments that target the dangerous embryonic properties of cancer stem cells, which form the basis for cancer growth, spread, and resistance to chemotherapy. Remedy Plan is positioned to deliver one first-in-class drug candidate for Phase I clinical development approximately ... 15 months after Series A funding Remedy Plan's proprietary drug screening platform identifies drug candidates that differentiate cancer stem cells, disrupt proliferation, and inhibit formation of new tumors. From the initial screen of 40,000 drug components, a lead candidate is currently undergoing optimization and mechanism of action studies in preparation for Phase I clinical trials. With the second screen of over 100,000 drug components completed, Remedy Plan aims to have at least two drugs in clinical development by 2020.

#SimilarOrganizations #People #Financial #Website #More

REMEDY PLAN THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Diagnostics Medical Therapeutics

Founded:
2011-01-01

Address:
Gaithersburg, Maryland, United States

Country:
United States

Website Url:
http://www.remedyplan.com

Total Employee:
1+

Status:
Active

Contact:
240-459-3985

Email Addresses:
[email protected]

Total Funding:
10.1 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Euro Microsoft Exchange Online


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

animated-dynamics-logo

Animated Dynamics

Animated Dynamics (AniDyn) Inc. is located in the Kurz Purdue Technology Center in West Lafayette IN.

chronix-biomedical-logo

Chronix Biomedical

Chronix Biomedical is a molecular diagnostics company developing blood tests for monitoring minimal residual disease in cancer patients.

lexagene-logo

LexaGene

LexaGene is a molecular diagnostics company that develops the MiQLabโ„ข system for the detection of pathogens and other molecular markers.

medchem-partners-logo

MedChem Partners

MedChem Partners is a medicinal chemistry CRO that specializes in developing small molecule therapeutics.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

sunny-dental-logo

Sunny Dental

Sunny Dental providing more professional orthodontics, implants, prosthetics, children's oral cavity and dental pulp.

tisenc-logo

Tisenc

Tisenc is engaged in the R&D and production of single-person automatic chemiluminescence analyzer.

trice-orthopedics-logo

Trice Orthopedics

Trice was founded to fundamentally improve orthopedic diagnostics and therapeutics by enabling instant and accurate office-based procedures.

xcell-biosciences-logo

Xcell Biosciences

Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.


Current Advisors List

daniel-porrtnoy_image

Daniel Porrtnoy Scientific Advisory Board @ Remedy Plan Therapeutics
Advisor
2016-01-15

alexandra-manick_image

Alexandra Manick Board Member @ Remedy Plan Therapeutics
Board_member

Current Employees Featured

gregory-crimmins_image

Gregory Crimmins
Gregory Crimmins CEO & Scientist @ Remedy Plan Therapeutics
CEO & Scientist
2016-01-15

dennise-a-de-jesus-diaz_image

Dennise A De Jesus-Diaz
Dennise A De Jesus-Diaz VP of Scientific Operations @ Remedy Plan Therapeutics
VP of Scientific Operations
2018-12-01

dennise-a-de-jesus-diaz_image

Dennise A De Jesus-Diaz
Dennise A De Jesus-Diaz Director Scientific Operations @ Remedy Plan Therapeutics
Director Scientific Operations
2017-04-21

not_available_image

Ronald Parchem
Ronald Parchem Founder @ Remedy Plan Therapeutics
Founder

Founder


greg-crimmins_image

Greg Crimmins

gregory-crimmins_image

Gregory Crimmins

not_available_image

Ronald Parchem

Investors List

schooner-capital_image

Schooner Capital

Schooner Capital investment in Venture Round - Remedy Plan Therapeutics

Official Site Inspections

http://www.remedyplan.com

  • Host name: 104.21.44.147
  • IP address: 104.21.44.147
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Remedy Plan Therapeutics"

Remedy Plan

Remedy Plan is a biotechnology company developing the first drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis.See details»

Team- Remedy Plan

Talented laboratory scientists, medicinal chemists, and biotech leaders with successful track records in oncological drug development. Greg has a PhD in molecular biology from University โ€ฆSee details»

Remedy Plan Therapeutics - Crunchbase Company โ€ฆ

Remedy Plan Therapeutics is a pre-clinical-stage company developing small molecule therapeutics to halt tumor growth and disrupt the cancer stem cells โ€ฆSee details»

Remedy Plan - Craft

Remedy Plan Therapeutics is a biotechnology company developing drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis. It offers a drug screening platform โ€ฆSee details»

Remedy Plan - Overview, News & Similar companies - ZoomInfo

View Remedy Plan (www.remedyplan.com) location in Maryland, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โ€ฆSee details»

Currently Hiring - Remedy Plan

Remedy Plan is a team of scientists and biotech entrepreneurs dedicated to tackling the biggest health problem of our time. We'll send you updates every few months, and will never share โ€ฆSee details»

Remedy Plan Therapeutics - LinkedIn

Remedy Plan Therapeutics is a small molecule therapeutics start-up company transforming the field of NAMPT inhibition, with a pioneering approach that allows for hyperbolic inhibition of NAMPT...See details»

Remedy Plan Therapeutics - PitchBook

Sep 21, 2018ย ยท Developer of medical drugs designed to halt tumor growth and prevent cancer. The company's drugs disrupt cancer stem cells by transforming the field of NAMPT inhibition with an approach that allows for hyperbolic โ€ฆSee details»

Remedy Plan - Products, Competitors, Financials, Employees ...

Remedy Plan is a biotechnology company focused on developing novel therapeutics in the field of NAMPT inhibition. The company's main offerings include a proprietary drug screening platform โ€ฆSee details»

Remedy Plan Therapeutics Expands Leadership Team โ€ฆ

Dec 6, 2023ย ยท Remedy Plan is a small molecule therapeutics start-up company transforming the field of NAMPT inhibition, with a pioneering approach that allows for allosteric inhibition of NAMPT that is...See details»

Remedy Plan Therapeutics Expands Leadership Team and Board

Dec 6, 2023ย ยท Remedy Plan Therapeutics, a small molecule therapeutics start-up company transforming the field of NAMPT inhibition, is pleased to announce the expansion of its โ€ฆSee details»

Remedy Plan Therapeutics Expands Leadership Team and Board of โ€ฆ

Dec 7, 2023ย ยท Remedy Plan is a small molecule therapeutics start-up company transforming the field of NAMPT inhibition, with a pioneering approach that allows for allosteric inhibition of โ€ฆSee details»

Pipeline- Remedy Plan

Remedy Plan is a team of scientists and biotech entrepreneurs dedicated to tackling the biggest health problem of our time. Tracks the drug development progress of multiple drug candidates, โ€ฆSee details»

Remedy Plan Therapeutics to Showcase Novel NAMPT Inhibitor โ€ฆ

Dec 10, 2023ย ยท Remedy Plan is a small molecule therapeutics start-up company transforming the field of NAMPT inhibition, with a pioneering approach that allows for allosteric inhibition of โ€ฆSee details»

Remedy Plan Therapeutics to Showcase Novel ... - The Malaysian โ€ฆ

Dec 11, 2023ย ยท Remedy Plan is a small molecule therapeutics start-up company transforming the field of NAMPT inhibition, with a pioneering approach that allows for allosteric inhibition of โ€ฆSee details»

Remedy Plan Therapeutics to Showcase Novel NAMPT Inhibitor โ€ฆ

Dec 10, 2023ย ยท Remedy Plan is a small molecule therapeutics start-up company transforming the field of NAMPT inhibition, with a pioneering approach that allows for allosteric inhibition of โ€ฆSee details»

Remedy Plan Therapeutics to Showcase Novel NAMPT Inhibitor โ€ฆ

Remedy Plan will present data on RPT1G, a clinical drug candidate for the treatment of solid and hematological malignancies. RPT1G is a small molecule NAMPT inhibitor with a unique,...See details»

Currently Hiring: Scientist I, Medicinal Chemistry - Remedy Plan

Remedy Plan is a cancer therapeutics company developing a pipeline of exciting small molecule drugs that cause cancer stem cells to differentiate and exhibit activity across multiple โ€ฆSee details»

Remedy Plan | Washington D.C. DC - Facebook

Remedy Plan, Washington D. C. 3,186 likes. We're developing the first drugs that stop the spread of cancer, instead of attacking both cancer an.See details»

Investors and Media- Remedy Plan

Source of information for new investors and press releasesSee details»

linkstock.net © 2022. All rights reserved